Joint Letter to the 66th World Health Assembly: Follow-up of the report of the CEWG
20 May 2013
Distinguished Delegate,
We urge the World Health Organization (WHO) and its Member States to exercise leadership, ambition and innovative thinking in developing new paradigms to take forward the work of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) in reconciling the objectives of stimulating medical innovation and ensuring access for all.
Continue Reading →
On Thursday May 30, 2013, the leaders of the MPAA and the NFB issued a joint statement, followed by a joint press call involving Chris Dodd, the CEO of the MPAA, and Rick Maurer, the President of the NFB. The… Continue Reading →
Note, we are adding some video clips from the meeting here:
May 13, 2013. KEI meeting on WIPO negotiations. http://www.youtube.com/playlist?list=PLLw9jWaZPEpzafm6_61VtLb6aW-nFaINa
On May 13, 2013, KEI will host a 12:30 to 2:30 brown bag lunch for a discussion of the WIPO Treaty for the Blind negotiations. It will be possible to attend in person, or follow the meeting on the telephone.
Continue Reading →
On April 15, 2013, the Intellectual Property Owners Association (IPO) sent a letter to Teresa Stanek Rea, the Acting Under Secretary of Commerce for Intellectual Property and the Director of the U.S. Patent and Trademark Office, setting out the IPO “concerns” about the proposed WIPO treaty for persons who are blind or visually impaired. (Copy here).
Continue Reading →
On April 26, 2013 I attended a half day meeting on “A Human Rights Approach to Intellectual Property and Access to Medicines” organized by the Yale Law School and the Yale School of Public Health. These are notes from my interventions on behalf of KEI.
1. KEI does a lot of work on intellectual property rights that has impact on human rights. We do not always give prominence to human rights law or the language of human rights, although at times and in the right context, it can be important to do so.
Continue Reading →
On 18 December 2012 and 20 December 2012, the World Trade Organization (WTO) undertook a trade policy review of the United States of America. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The questions raised by WTO Members during the US TPR touched upon on compulsory licensing (including cases of judicial compulsory licensing following eBay v. MercExchange), copyright (Golan v. Holder), the Special 301 report and the Medicines Patent Pool. On 30 April 2013, the WTO released the records of the meeting including WT/TPR/M/275. Continue Reading →
The WBU just issued the attached press release. (On a related note, a video of their statement Saturday morning is available here).
WORLD BLIND UNION (WBU) press release 20th April 2013
Press Release – WIPO Negotiations Treaty for Blind people
A treaty for the blind or for the rights holders?
Continue Reading →
As mentioned in our piece, State of Play: Treaty for the Blind negotiations at the World Intellectual Property Organization, the February 2013 special session of the WIPO Standing Committee on Copyright and Related Rights (SCCR) reached agreement on a cluster of provisions on the Treaty’s treatment of the copyright three-step test that resulted in the ARTICLE(S) section contained in SCCR/25/2/Rev. Continue Reading →
In Geneva this week the US government is taking a harder line in the WIPO negotiations for a treaty on copyright exceptions for the blind, and the reason is simple — lobbyists for the MPAA and publishers have been all over the White House, demanding a retreat from compromises made in February, and demanding that the Obama Administration push new global standards for technical protection measures, strip the treaty text of any reference to fair use and fair dealing, and impose new financial liabilities on libraries that serve blind people. Continue Reading →
On 15 April 2013, the Supreme Court of the United States heard oral arguments in the case Association for Molecular Pathology, et. al., v. Myriad Genetics, et. al, hearing arguments over the question: are human genes patentable? The case, which has been litigated since 2009, specifically involves two genes, known as the BRCA1 and BRCA2 genes which are associated with an individual’s susceptibility to breast and ovarian cancer. Continue Reading →
